Literature DB >> 18971322

Crystal structure of an RNA aptamer bound to thrombin.

Stephen B Long1, Meredith B Long, Rebekah R White, Bruce A Sullenger.   

Abstract

Aptamers, an emerging class of therapeutics, are DNA or RNA molecules that are selected to bind molecular targets that range from small organic compounds to large proteins. All of the determined structures of aptamers in complex with small molecule targets show that aptamers cage such ligands. In structures of aptamers in complex with proteins that naturally bind nucleic acid, the aptamers occupy the nucleic acid binding site and often mimic the natural interactions. Here we present a crystal structure of an RNA aptamer bound to human thrombin, a protein that does not naturally bind nucleic acid, at 1.9 A resolution. The aptamer, which adheres to thrombin at the binding site for heparin, presents an extended molecular surface that is complementary to the protein. Protein recognition involves the stacking of single-stranded adenine bases at the core of the tertiary fold with arginine side chains. These results exemplify how RNA aptamers can fold into intricate conformations that allow them to interact closely with extended surfaces on non-RNA binding proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971322      PMCID: PMC2590953          DOI: 10.1261/rna.1239308

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  57 in total

1.  The penultimate rotamer library.

Authors:  S C Lovell; J M Word; J S Richardson; D C Richardson
Journal:  Proteins       Date:  2000-08-15

2.  Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer.

Authors:  J Colin Cox; Andrew Hayhurst; Jay Hesselberth; Travis S Bayer; George Georgiou; Andrew D Ellington
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

3.  Protein-RNA interactions: exploring binding patterns with a three-dimensional superposition analysis of high resolution structures.

Authors:  N Morozova; J Allers; J Myers; Y Shamoo
Journal:  Bioinformatics       Date:  2006-09-11       Impact factor: 6.937

4.  Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function.

Authors:  J Ishizaki; J R Nevins; B A Sullenger
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

5.  The structural basis for molecular recognition by the vitamin B 12 RNA aptamer.

Authors:  D Sussman; J C Nix; C Wilson
Journal:  Nat Struct Biol       Date:  2000-01

Review 6.  Thrombin interactions.

Authors:  Enrico Di Cera
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

7.  The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.

Authors:  Alexey Dementiev; Maurice Petitou; Jean-Marc Herbert; Peter G W Gettins
Journal:  Nat Struct Mol Biol       Date:  2004-08-15       Impact factor: 15.369

8.  Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha.

Authors:  Reha Celikel; Richard A McClintock; James R Roberts; G Loredana Mendolicchio; Jerry Ware; Kottayil I Varughese; Zaverio M Ruggeri
Journal:  Science       Date:  2003-07-11       Impact factor: 47.728

9.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

10.  Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.

Authors:  Wei Li; Daniel J D Johnson; Charles T Esmon; James A Huntington
Journal:  Nat Struct Mol Biol       Date:  2004-08-15       Impact factor: 15.369

View more
  52 in total

1.  Atomic mutagenesis reveals A2660 of 23S ribosomal RNA as key to EF-G GTPase activation.

Authors:  Nina Clementi; Anna Chirkova; Barbara Puffer; Ronald Micura; Norbert Polacek
Journal:  Nat Chem Biol       Date:  2010-03-28       Impact factor: 15.040

Review 2.  Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine.

Authors:  Thomas J Povsic; Bruce A Sullenger; Steven L Zelenkofske; Christopher P Rusconi; Richard C Becker
Journal:  J Cardiovasc Transl Res       Date:  2010-11-16       Impact factor: 4.132

Review 3.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

Review 4.  Modulation of the Coagulation Cascade Using Aptamers.

Authors:  Rebecca S Woodruff; Bruce A Sullenger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-27       Impact factor: 8.311

5.  A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.

Authors:  K-A Steen Burrell; J Layzer; B A Sullenger
Journal:  J Thromb Haemost       Date:  2017-08-02       Impact factor: 5.824

6.  Long range communication between exosites 1 and 2 modulates thrombin function.

Authors:  Nicolas S Petrera; Alan R Stafford; Beverly A Leslie; Colin A Kretz; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

7.  Label-Free Electrophoretic Mobility Shift Assay (EMSA) for Measuring Dissociation Constants of Protein-RNA Complexes.

Authors:  Minguk Seo; Li Lei; Martin Egli
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2018-11-21

8.  Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.

Authors:  Kenneth A Botkjaer; Elena I Deryugina; Daniel M Dupont; Henrik Gårdsvoll; Erin M Bekes; Cathrine K Thuesen; Zhuo Chen; Zhou Chen; Michael Ploug; James P Quigley; Peter A Andreasen
Journal:  Mol Cancer Res       Date:  2012-10-04       Impact factor: 5.852

9.  Binding of an RNA aptamer and a partial peptide of a prion protein: crucial importance of water entropy in molecular recognition.

Authors:  Tomohiko Hayashi; Hiraku Oshima; Tsukasa Mashima; Takashi Nagata; Masato Katahira; Masahiro Kinoshita
Journal:  Nucleic Acids Res       Date:  2014-05-06       Impact factor: 16.971

10.  Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency.

Authors:  Maximilian C R Buff; Florian Schäfer; Bernhard Wulffen; Jens Müller; Bernd Pötzsch; Alexander Heckel; Günter Mayer
Journal:  Nucleic Acids Res       Date:  2009-12-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.